The interface between the blood and brain is vital for the protection of neurological processes. A key regulatory mechanism of the blood–brain border (BBB) is the circadian rhythm, an intrinsic timekeeping system that maintains 24-h rhythms. At the BBB, the endothelial cell clock has been implicated in time-of-day differences in removal of drugs from the brain; however, pharmacologic modulation of the BBB clock remains unexplored. To investigate circadian dynamics in the BBB, we isolated murine brain microvessels (MVs) and used a Color-Switch PER2::iLuc system to longitudinally monitor rhythms. Isolated MVs consisting of endothelial cells and pericytes preserved vascular morphology for 4 days and circadian oscillations were maintained ex vivo under forskolin synchronization. MVs were treated with known small-molecule modulators of the circadian clock including flavonoids; nobiletin, tangeretin, sinensetin; a CLOCK inhibitor CLK8; CRY stabilizer KL001; and REV-ERBα agonist SR9009. Of these, sinensetin increased rhythms and KL001 decreased rhythms consistently in both MVs and a human microvascular cell line. KL001 and sinensetin administration to mice altered circadian gene expression and BBB circadian rhythms of efflux. These findings establish that BBB circadian rhythms are pharmacologically tractable and highlight small-molecule modulators as promising tools to optimize CNS drug delivery using chronopharmacology.
PardridgeWM.The blood–brain barrier: bottleneck in brain drug development. NeuroRx2005; 2: 3–14.
2.
AbbottNJPatabendigeAAKDolmanDEM, et al. Structure and function of the blood–brain barrier. Neurobiol Dis2010; 37: 13–25.
3.
ArmulikAGenovéGMäeM, et al. Pericytes regulate the blood–brain barrier. Nature2010; 468: 557–561.
4.
AbbottNJRönnbäckLHanssonE.Astrocyte-endothelial interactions at the blood–brain barrier. Nat Rev Neurosci2006; 7: 41–53.
5.
Cordon-CardoCO’BrienJPCasalsD, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites. Proc Natl Acad Sci U S A1989; 86: 695–698.
6.
SchneebergerEELynchRD.The tight junction: a multifunctional complex. Am J Physiol Cell Physiol2004; 286; 286(6): C1213–C1228.
7.
SchinkelAHSmitJJMvan TellingenO, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs. Cell1994; 77: 491–502.
8.
BalayssacDCayreAAuthierN, et al. Patterns of P-glycoprotein activity in the nervous system during vincristine-induced neuropathy in rats. J Peripher Nerv Syst2005; 10: 301–310.
9.
JangSHGuillaume WientjesM, et al. Kinetics of P-glycoprotein-mediated efflux of paclitaxel. J Pharmacol Exp Ther2001; 298: 1236–1242.
10.
Van VlietEAVan SchaikREdelbroekPM, et al. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia2006; 47: 672–680.
11.
PulidoRSMunjiRNChanTC, et al. Neuronal activity regulates blood–brain barrier efflux transport through endothelial circadian genes. Neuron2020; 108: 937–952.e7.
12.
ZhangSLLahensNFYueZ, et al. A circadian clock regulates efflux by the blood–brain barrier in mice and human cells. Nat Commun2021; 12: 1–12.
13.
ZhangSLYueZArnoldDM, et al. A circadian clock in the blood–brain barrier regulates xenobiotic efflux. Cell2018; 173: 130–139.e10.
14.
HastingsMHReddyABMaywoodES.A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci2003; 4: 649–661.
15.
MohawkJAGreenCBTakahashiJS.Central and peripheral circadian clocks in mammals. Annu Rev Neurosci2012; 35: 445–462.
16.
StorchKFLipanOLeykinI, et al. Extensive and divergent circadian gene expression in liver and heart. Nature2002; 417: 78–83.
17.
McCarthyJJAndrewsJLMcDearmonEL, et al. Identification of the circadian transcriptome in adult mouse skeletal muscle. Physiol Genomics2007; 31: 86–95.
18.
DunlapJC.Molecular bases for circadian clocks. Cell1999; 96: 271–290.
19.
ReppertSMWeaverDR.Coordination of circadian timing in mammals. Nature2002; 418: 935–941.
20.
AkashiMOkamotoATsuchiyaY, et al. A positive role for PERIOD in mammalian circadian gene expression. Cell Rep2014; 7: 1056–1064.
21.
YeRSelbyCPChiouYY, et al. Dual modes of CLOCK:BMAL1 inhibition mediated by cryptochrome and period proteins in the mammalian circadian clock. Genes Dev2014; 28: 1989–1998.
22.
PreitnerNDamiolaFLuis-Lopez-Molina, et al. The orphan nuclear receptor REV–ERBα controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell2002; 110: 251–260.
23.
SatoTKPandaSMiragliaLJ, et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron2004; 43: 527–537.
24.
TakedaYJothiRBiraultV, et al. RORγ directly regulates the circadian expression of clock genes and downstream targets in vivo. Nucleic Acids Res2012; 40: 8519–8535.
25.
TakahashiJS.Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet2017; 18: 164–179.
26.
KojimaSShingleDLGreenCB.Post-transcriptional control of circadian rhythms. J Cell Sci2011; 124: 311–320.
27.
ZhangEELiuYDentinR, et al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat Med2010; 16: 1152–1156.
28.
PandaSAntochMPMillerBH, et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell2002; 109: 307–320.
29.
MasriSPatelVREckel-MahanKL, et al. Circadian acetylome reveals regulation of mitochondrial metabolic pathways. Proc Natl Acad Sci U S A2013; 110: 3339–3344.
30.
WalkerWHWaltonJCDeVriesAC, et al. Circadian rhythm disruption and mental health. Transl Psychiatry2020; 10(1): 28.
31.
ChenCYLoganRWMaT, et al. Effects of aging on circadian patterns of gene expression in the human prefrontal cortex. Proc Natl Acad Sci U S A2016; 113: 206–211.
32.
MauryERamseyKMBassJ.Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ Res2010; 106: 447–462.
33.
TakedaNMaemuraK.Circadian clock and cardiovascular disease. J Cardiol2011; 57: 249–256.
34.
ShanYAbelJHLiY, et al. Dual-color single-cell imaging of the suprachiasmatic nucleus reveals a circadian role in network synchrony. Neuron2020; 108: 164–179.e7.
35.
RibeiroRFNCavadasCSilvaMMC.Small-molecule modulators of the circadian clock: pharmacological potentials in circadian-related diseases. Drug Discov Today2021; 26: 1620–1641.
36.
YagitaKOkamuraH.Forskolin induces circadian gene expression of rPer1, rPer2 and dbp in mammalian rat-1 fibroblasts. FEBS Lett2000; 465: 79–82.
37.
HeBNoharaKParkN, et al. The small molecule Nobiletin targets the molecular oscillator to enhance circadian rhythms and protect against metabolic syndrome. Cell Metab2016; 23: 610.
38.
SoltLAWangYBanerjeeS, et al. Regulation of circadian behaviour and metabolism by synthetic REV–ERB agonists. Nature2012; 485(7396): 62–68.
39.
HirotaTLeeJWSt JohnPC, et al. Identification of small molecule activators of cryptochrome. Science2012; 337: 1094–1097.
40.
StorchKFWeitzCJ.Daily rhythms of food-anticipatory behavioral activity do not require the known circadian clock. Proc Natl Acad Sci U S A2009; 106: 6808–6813.
41.
KisanukiYYHammerREMiyazakiJ, et al. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol2001; 230: 230–242.
42.
PercieduSertNHurstVAhluwaliaA, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Cereb Blood Flow Metab2020; 40: 1769–1777.
43.
LeeYKUchidaHSmithH, et al. The isolation and molecular characterization of cerebral microvessels. Nat Protoc2019; 14: 3059–3081.
44.
ParaisoHCWangXKuoPC, et al. Isolation of mouse cerebral microvasculature for molecular and single-cell analysis. Front Cell Neurosci2020; 14: 84.
45.
BjørnholmKDDel GaudioFLiH, et al. A robust and efficient microvascular isolation method for multimodal characterization of the mouse brain vasculature. Cell Rep Methods2023; 3(3): 100431.
46.
RamanathanCKhanSKKathaleND, et al. Monitoring cell-autonomous circadian clock rhythms of gene expression using luciferase bioluminescence reporters. J Vis Exp2012; 2012(67): 4234.
47.
PollerBGutmannHKrähenbühlS, et al. The human brain endothelial cell line hCMEC/D3 as a human blood–brain barrier model for drug transport studies. J Neurochem2008; 107: 1358–1368.
48.
ZielińskiTHayJMillarAJ.Period estimation and rhythm detection in timeseries data using BioDare2, the free, online, community resource. Methods Mol Biol2022; 2398: 15–32.
49.
OrnelasSBerthiaumeAABonneySK, et al. Three-dimensional ultrastructure of the brain pericyte–endothelial interface. J Cereb Blood Flow Metab2021; 41: 2185–2200.
50.
PayneLBDardenJSuarez-MartinezAD, et al. Pericyte migration and proliferation are tightly synchronized to endothelial cell sprouting dynamics. Integr Biol2021; 13: 31–43.
51.
SongNHuangYShiH, et al. Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1α/CXCR4 axis. Cancer Res2009; 69: 6057–6064.
52.
PelloweASWuMJKangTY, et al. TGF-β1 drives integrin-dependent pericyte migration and microvascular destabilization in fibrotic disease. Am J Pathol2024; 194: 1171–1184.
53.
BohnKAAdkinsCEMittapalliRK, et al. Semi-automated rapid quantification of brain vessel density utilizing fluorescent microscopy. J Neurosci Methods2016; 270: 124–131.
54.
TangYHarringtonAYangX, et al. The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells. Genesis2010; 48: 563–567.
55.
IinumaMMatsuuraSKurogochiK, et al. Studies on the constituents of useful plants. V. Multisubstituted flavones in the fruit peel of Citrus reticulata and their examination by gas–liquid chromatography. Chem Pharm Bull1980; 28: 717–722.
56.
WangYSongBChenJ, et al. Polymethoxyflavones in citrus regulate lipopolysaccharide-induced oscillating decay of circadian rhythm genes by inhibiting Nlrp3 expression. Oxid Med Cell Longev2021; 2021: 8419415.
57.
LiuACWelshDKKoCH, et al. Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell2007; 129: 605–616.
58.
YooSHYamazakiSLowreyPL, et al. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc Natl Acad Sci U S A2004; 101: 5339–5346.
59.
MartignoniMGroothuisGMMde KanterR.Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol2006; 2: 875–894.
60.
PizarroAHayerKLahensNF, et al. CircaDB: a database of mammalian circadian gene expression profiles. Nucleic Acids Res2013; 41: D1009–D1013.
61.
DorukYUYarparvarDAkyelYK, et al. A CLOCK-binding small molecule disrupts the interaction between CLOCK and BMAL1 and enhances circadian rhythm amplitude. J Biol Chem2020; 295: 3518–3531.
62.
Mertens-TalcottSUDe CastroWVMantheyJA, et al. Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells. J Agric Food Chem2007; 55: 2563–2568.
63.
ShinozakiAMisawaKIkedaY, et al. Potent effects of flavonoid nobiletin on amplitude, period, and phase of the circadian clock rhythm in PER2::LUCIFERASE mouse embryonic fibroblasts. PLoS One2017; 12(2): e0170904.
64.
St JohnPCTaylorSRAbelJH, et al. Amplitude metrics for cellular circadian bioluminescence reporters. Biophys J2014; 107: 2712.
65.
PulivarthySRTanakaNWelshDK, et al. Reciprocity between phase shifts and amplitude changes in the mammalian circadian clock. Proc Natl Acad Sci U S A2007; 104: 20356–20361.
66.
BernardSGonzeDČajavecB, et al. Synchronization-induced rhythmicity of circadian oscillators in the suprachiasmatic nucleus. PLoS Comput Biol2007; 3: e68.
67.
MantheyJAGrohmannK.Phenols in citrus peel byproducts. Concentrations of hydroxycinnamates and polymethoxylated flavones in citrus peel molasses. J Agric Food Chem2001; 49: 3268–3273.
68.
BarbosaFHorvathD.Molecular similarity and property similarity. Curr Top Med Chem2005; 4: 589–600.
69.
KimEMawatariKYooSH, et al. The circadian Nobiletin–ROR axis suppresses adipogenic differentiation and IκBα/NF-κB signaling in adipocytes. Nutrients2023; 15(18): 3919.
70.
Lellupitiyage DonSSRobertsonKLLinHH, et al. Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner. PLoS One2020; 15(7): e0236315.
71.
RosatoETauberEKyriacouCP.Molecular genetics of the fruit-fly circadian clock. Eur J Hum Genet2006; 14: 729–738.
72.
BaiJZhaoSFanX, et al. Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: food/herb–drug interactions and structure–activity relationships. Toxicol Appl Pharmacol2019; 369: 49–59.
73.
OhdoS.Changes in toxicity and effectiveness with timing of drug administration: implications for drug safety. Drug Saf2003; 26(14): 999–1010.
74.
QianDCKleberTBrammerB, et al. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study. Lancet Oncol2021; 22: 1777–1786.
75.
WaltonJCWalkerWHBumgarnerJR, et al. Circadian variation in efficacy of medications. Clin Pharmacol Ther2021; 109: 1457–1488.
76.
KrishnaRMayerLD.Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci2000; 11: 265–283.
77.
PotschkaHFedrowitzMLöscherW.P-glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood–brain barrier: evidence from microdialysis experiments in rats. Neurosci Lett2002; 327: 173–176.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
